5-chloro-6-azido-5,6-dihydro-2'-deoxyuridine

• 分子结构分类: 有机化合物 - 核苷、核苷酸和类似物 - 嘧啶核苷
• 英文名称: 5-chloro-6-azido-5,6-dihydro-2'-deoxyuridine
• 英文别名: 6-azido-5-chloro-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]hexahydropyrimidine-2,4-dione；6-azido-5-chloro-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3-diazinane-2,4-dione
• 化学式: C₉H₁₂ClN₅O₅
• 分子量: 305.678
• InChiKey: VYMPYTLUKYXYBC-YXLNOIRLSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.3
• 重原子数：
  20
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.78
• 拓扑面积：
  114
• 氢给体数：
  3
• 氢受体数：
  7

反应信息

• 作为产物：
  描述：

  2-脱氧尿苷 在 N-氯代丁二酰亚胺 、 sodium azide 作用下， 以 乙二醇二甲醚 、 水 为溶剂， 反应 12.0h， 生成 5-chloro-6-azido-5,6-dihydro-2'-deoxyuridine
  参考文献：
  名称：

  5-Bromo (or chloro)-6-azido-5,6-dihydro-2′-deoxyuridine and -thymidine derivatives with potent antiviral activity

  摘要：

  Synthesis, antiviral, and cytotoxic activities of 5-bromo (or chloro)-6-azido-5,6-dihydro-2'-deoxyuridine (4,5) and -thymidine (6,7) are reported. Compounds 4 and 5 exhibited a broad spectrum of antiherpes activity against (HSV-1, HSV-2, HCMV, and VZV). (C) 2002 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(01)00735-1

文献信息

• Method for Preparing Nanoparticles Based on Functional Amphiphilic Molecules or Macromolecules, and the Use Thereof
  申请人：Barthelemy Philippe

  公开号：US20110059180A1

  公开（公告）日：2011-03-10

  The invention relates to a method for preparing nanoparticles based on functional amphiphilic molecules or macromolecules, optionally in the presence of at least one colipide, enabling the encapsulation of therapeutic agents, especially anti-tumoral agents, and the use thereof for the transport and vectorisation of therapeutic agents, especially anti-tumoral agents.

  这项发明涉及一种基于功能性两性分子或大分子制备纳米颗粒的方法，可选地在至少一种胆固醇类物质的存在下，使治疗剂，特别是抗肿瘤剂的封装成为可能，并且用于运输和载体化治疗剂，特别是抗肿瘤剂。
• FUNCTIONAL AMPHIPILIC MOLECULE OR MACROMOLECULE FORMULATIONS WITH MULTIPLE COMPARTMENTS
  申请人：Barthelemy Philippe

  公开号：US20120070505A1

  公开（公告）日：2012-03-22

  The invention relates to novel functional amphiphilic molecule or macromolecule formulations with multiple compartments for transporting or targeting at least one therapeutic agent, in particular an antitumor agent, as well as to a method for preparing such formulations and to the use thereof.

  本发明涉及一种新型的具有多个隔室的功能性两性分子或大分子配方，用于运输或靶向至少一种治疗剂，特别是抗肿瘤剂，以及制备这种配方的方法和使用方法。
• ANTIVIRAL NUCLEOSIDES
  申请人：Kumar Rakesh

  公开号：US20100130440A1

  公开（公告）日：2010-05-27

  Disclosed are nucleosides which are useful in diagnosing and treating viral infections, for example, infections caused by hepatitis B virus (HBV), and herpes viruses including Epstein Barr virus.

  本发明涉及一种核苷，其在诊断和治疗病毒感染中有用，例如由乙型肝炎病毒（HBV）和包括Epstein-Barr病毒在内的疱疹病毒引起的感染。
• METHOD FOR PREPARING NANOPARTICLES BASED ON FUNCTIONAL AMPHIPHILIC MOLECULES OR MACROMOLECULES, AND THE USE THEREOF
  申请人：UNIVERSITE VICTOR SEGALEN BORDEAUX 2

  公开号：US20140308343A1

  公开（公告）日：2014-10-16

  The invention relates to a method for preparing nanoparticles based on functional amphiphilic molecules or macromolecules, optionally in the presence of at least one colipide, enabling the encapsulation of therapeutic agents, especially anti-tumoral agents, and the use thereof for the transport and vectorization of therapeutic agents, especially anti-tumoral agents.

  本发明涉及一种基于功能性两亲分子或大分子的纳米粒子制备方法，可选地在至少一种胆固醇类物质的存在下，使治疗剂，特别是抗肿瘤剂封装，并用于治疗剂，特别是抗肿瘤剂的输送和载荷。
• Antiviral nucleosides
  申请人：Kumar, Rakesh

  公开号：EP2322534A1

  公开（公告）日：2011-05-18

  Disclosed are nucleosides which are useful in diagnosing and treating viral infections, for example, infections caused by hepatitis B virus (HBV), and herpes viruses including Epstein Barr virus

  所公开的核苷类药物可用于诊断和治疗病毒感染，例如由乙型肝炎病毒（HBV）和疱疹病毒（包括 Epstein Barr 病毒）引起的感染。